Ph II CHOP+Velcade in Mediastinal LBCL

NCT00361621 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Closed due to slow accrual

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: bortezomib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
RADIATION: Radiation therapy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]